Head Lice Infestation Clinical Trial
Official title:
Comparative, Monocentric Study for the Evaluation of the Efficacy of Two Medical Devices on the Treatment of Head Lice Infestation
Pediculosis capitis or head lice infestation is a human medical condition caused by the infestation of the hair by the parasitic insect Pediculus humanus capitis (human head lice). The most common symptom of infestation is pruritus (itching) on the head which normally intensifies 3 to 4 weeks after the initial infestation. The test items have been developed with the ambition to offer a complete head lice treatment, whilst also offering ultimative convenience in use - making treatment of head lice infestation easy, and effective in few minutes. The main objective of this clinical study is to confirm the efficacy on head lice treatment of two Medical Devices, already in market.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02097485 -
Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
|
Phase 2 | |
| Recruiting |
NCT04878276 -
Comparative Head Lice Therapy With Dimet 5® vs. Hedrin® Once
|
||
| Completed |
NCT01907490 -
Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation
|
Phase 2 | |
| Completed |
NCT02060903 -
A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
|
Phase 3 | |
| Completed |
NCT02062060 -
Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
|
Phase 3 | |
| Completed |
NCT02010333 -
A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation
|
Phase 2 |